You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 62135-0739


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 62135-0739

Drug NameNDCPrice/Unit ($)UnitDate
NIFEDIPINE 10 MG CAPSULE 62135-0739-90 0.28545 EACH 2025-04-23
NIFEDIPINE 10 MG CAPSULE 62135-0739-90 0.30279 EACH 2025-03-19
NIFEDIPINE 10 MG CAPSULE 62135-0739-90 0.30231 EACH 2025-02-19
NIFEDIPINE 10 MG CAPSULE 62135-0739-90 0.27437 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 62135-0739

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for NDC 62135-0739

Understanding the NDC System

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC system entails. The NDC Directory, maintained by the FDA, contains information on finished, unfinished, and compounded drug products, including their marketing start and end dates, and other relevant details[1].

Identifying the Drug

The NDC 62135-0739 corresponds to a specific drug product. However, the provided sources do not directly mention this NDC. To proceed, we need to identify the drug associated with this NDC.

Drug Identification

While the specific drug associated with NDC 62135-0739 is not mentioned in the sources, we can infer the process of identification. Typically, one would refer to the FDA's NDC Directory or other pharmaceutical databases to identify the drug name, dosage form, and strength associated with this NDC.

Market Analysis

Life Sciences Industry Trends

The life sciences industry is undergoing significant transformations driven by digital advancements, scientific innovations, and changing market dynamics. Key trends include the impact of generic drugs and biosimilars, patent expirations, and the rise of innovative therapies such as immunotherapies and targeted therapies[3].

Pricing and Access

Pricing and access to drugs are significant concerns for the life sciences industry. Nearly half of the C-suite executives surveyed expect pricing and access issues to significantly affect their strategies in 2025. This trend is particularly relevant when analyzing the market for any drug, as pricing strategies can be influenced by regulatory, competitive, and market forces[3].

Price Projections

General Pricing Trends

For drugs in general, pricing trends can be influenced by several factors, including competition from generics and biosimilars, patent expirations, and the introduction of new therapies. For example, in the NSCLC market, the sales of patented drugs like Tarceva and Alimta are expected to decline significantly due to patent expirations, while generic versions are expected to gain traction[4].

Specific Drug Pricing

Without specific data on the drug associated with NDC 62135-0739, we can look at analogous examples. For instance, the price of Leflunomide (NDC 62135-0793), another drug, has shown variability over time, ranging from $0.267 to $0.404 per unit over different periods in 2024[2].

Factors Influencing Price

Competition and Generics

The presence of generic or biosimilar versions of a drug can significantly impact its pricing. As seen in the NSCLC market, the introduction of generic erlotinib and pemetrexed is expected to reduce the sales of their patented counterparts[4].

Regulatory Environment

Regulatory changes and compliance requirements can also affect drug pricing. For example, outsourcing facilities that compound human drug products may choose to assign NDCs to their products, which can influence pricing and market availability[1].

Market Demand and Therapeutic Area

The demand for a drug within its therapeutic area can also drive pricing. For instance, the growing demand for GLP-1 drugs in treating obesity and other conditions is expected to impact the broader life sciences and healthcare industry, potentially influencing pricing strategies[3].

Key Takeaways

  • NDC System: The FDA's NDC Directory is a critical resource for identifying and tracking drug products.
  • Market Trends: The life sciences industry is influenced by digital transformation, innovative therapies, and regulatory changes.
  • Pricing Factors: Competition from generics, patent expirations, and market demand are key factors influencing drug pricing.
  • Regulatory Compliance: Compliance with FDA regulations, including NDC assignments, is essential for market presence.

FAQs

  1. What is the NDC Directory?

    • The NDC Directory is a database maintained by the FDA that contains information on finished, unfinished, and compounded drug products, including their marketing start and end dates.
  2. How do generic drugs impact the pricing of branded drugs?

    • Generic drugs can significantly reduce the sales and pricing of branded drugs by offering cheaper alternatives, as seen in the NSCLC market with drugs like Tarceva and Alimta.
  3. What role do outsourcing facilities play in drug pricing?

    • Outsourcing facilities that compound human drug products may assign NDCs to their products, which can influence pricing and market availability.
  4. How do regulatory changes affect drug pricing?

    • Regulatory changes, such as those related to patent expirations and compliance requirements, can significantly impact drug pricing by altering the competitive landscape.
  5. What are the key trends in the life sciences industry for 2025?

    • Key trends include digital transformation, the rise of innovative therapies, and the impact of generic drugs and biosimilars on market strategies.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Latest pharmaceutical drug prices and trends for NDC 62135-0793 - DrugPatentWatch
  3. 2025 life sciences outlook - Deloitte Insights
  4. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development
  5. Drug Name and National Drug Code (NDC) Reference Data Instructions - CMS

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.